Stocks
Caribou Biosciences, Inc.CRBU
NASDAQHealthcareBiotechnology$0.47
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing CRISPR gene-edited cell therapies for cancer and autoimmune diseases. Its lead candidates target relapsed or refractory B-cell malignancies, with early data drawing attention from investors tracking the allogeneic CAR-T space. The company's platform aims to improve manufacturing scalability and patient access compared to autologous approaches.
52W Range: $0.44-$3.54
Congressional Interest in Caribou Biosciences, Inc. (CRBU)
No congressional trades have been disclosed for Caribou Biosciences, Inc. (CRBU) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading CRBU?
No congressional trades found for this stock.